192 related articles for article (PubMed ID: 32976563)
1. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
[TBL] [Abstract][Full Text] [Related]
3. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
4. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
Ahn SJ; Ryu SJ; Lim HW; Lee BR
Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
[TBL] [Abstract][Full Text] [Related]
5. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
6. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Fundus Autofluorescence in ABCA4-Related Retinopathy -Functional Relevance and Genotype-Phenotype Correlation.
Müller PL; Gliem M; McGuinnes M; Birtel J; Holz FG; Charbel Issa P
Am J Ophthalmol; 2021 Feb; 222():340-350. PubMed ID: 32891696
[TBL] [Abstract][Full Text] [Related]
9. Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.
Jauregui R; Parmann R; Nuzbrokh Y; Tsang SH; Sparrow JR
Transl Vis Sci Technol; 2020 Aug; 9(9):8. PubMed ID: 32879764
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
11. Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment.
Parrulli S; Cozzi M; Airaldi M; Romano F; Viola F; Sarzi-Puttini P; Staurenghi G; Invernizzi A
Clin Exp Ophthalmol; 2022 Jul; 50(5):500-509. PubMed ID: 35503294
[TBL] [Abstract][Full Text] [Related]
12. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
13. Central Serous Chorioretinopathy Analyzed by Multimodal Imaging.
Han L; de Carvalho JRL; Parmann R; Tezel TH; Chang S; Sharma T; Sparrow JR
Transl Vis Sci Technol; 2021 Jan; 10(1):15. PubMed ID: 33510954
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Imaging in Best Vitelliform Macular Dystrophy.
Lima de Carvalho JR; Paavo M; Chen L; Chiang J; Tsang SH; Sparrow JR
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2012-2022. PubMed ID: 31070670
[TBL] [Abstract][Full Text] [Related]
15. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
19. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
Tsang A; Kanda P; Gottlieb C; Virgili G; Kantungane L; Coupland S
Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206
[TBL] [Abstract][Full Text] [Related]
20. Comparison between multifocal ERG and C-Scan SD-OCT ("en face" OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results.
Arndt C; Costantini M; Chiquet C; Afriat M; Berthemy S; Vasseur V; Ducasse A; Mauget-Faÿsse M
Doc Ophthalmol; 2018 Apr; 136(2):97-111. PubMed ID: 29536324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
